Latest news
Insmed Reports Q2 2026 Revenue of $425.5M; Raises BRINSUPRI Guidance to $1.25B–$1.40B - TradingViewTradingView · Thu, 06 Aug 2026 11:03:01 GMTINSM: Q2 2026 revenues rose 296% to $425.5M, driven by BRINSUPRI and ARIKAYCE growth - TradingViewTradingView · Thu, 06 Aug 2026 11:01:40 GMTINSM: Q2 2026 revenue surged 296% to $425.5M, led by BRINSUPRI launch and ARIKAYCE growth - TradingViewTradingView · Thu, 06 Aug 2026 11:00:56 GMT